Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study
0
Zitationen
9
Autoren
2026
Jahr
Abstract
Our study highlights the promising performance of AI in clinical trial screening. Future work should explore integration with structured clinical data, such as laboratory values or radiological findings, to improve multimodal comprehension. Expanding the evaluation to a broader range of tumor types and multicenter datasets would improve generalizability. Finally, real-time prospective validation and workflow integration with electronic health records will be critical to assess the feasibility and clinical impact of large language model-assisted screening in daily oncology practice. Addressing these challenges will be essential to move from proof of concept to scalable clinical implementation.
Ähnliche Arbeiten
The Clavien-Dindo Classification of Surgical Complications
2009 · 10.966 Zit.
Radiomics: Images Are More than Pictures, They Are Data
2015 · 7.992 Zit.
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 · 7.608 Zit.
TGF-β SIGNAL TRANSDUCTION
1998 · 7.559 Zit.
Pancreatic Cancer
2000 · 7.244 Zit.